Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study.
Crimi C, Nolasco S, Noto A, Maglio A, Quaranta VN, Di Bona D, Scioscia G, Papia F, Caiaffa MF, Calabrese C, D'Amato M, Pelaia C, Campisi R, Vitale C, Ciampo L, Dragonieri S, Minenna E, Massaro F, Gallotti L, Macchia L, Triggiani M, Scichilone N, Valenti G, Pelaia G, Foschino Barbaro MP, Carpagnano GE, Vatrella A, Crimi N; Southern Italy Network on Severe Asthma Therapy.
Crimi C, et al.
J Allergy Clin Immunol Pract. 2024 Aug 27:S2213-2198(24)00852-3. doi: 10.1016/j.jaip.2024.08.033. Online ahead of print.
J Allergy Clin Immunol Pract. 2024.
PMID: 39197750
Free article.